Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.84 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Non Operating Investment Income (2022)

Updated

Bluejay Diagnostics' Non Operating Investment Income came in at -$210,117 for Q3 2022.

Analysis

Bluejay Diagnostics (BJDX) Non Operating Investment Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Bluejay Diagnostics 1.67 Mn 1.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -210,117.00
API Access

Bluejay Diagnostics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=BJDX&period=max&api_key=YOUR_API_KEY